OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Michelle James

1 Projects | 1 Researchers | $350,385 Invested

2025

Board of Trustees of the Leland Stanford Junior University

Michelle James, PhD

Development of new PET radiotracers for detecting and tracking innate immune activation in the whole body and CNS of Alzheimer's disease

  • Funding Amount: $350,385
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Active